Stephen Taub Premium Perceptive’s China Rx The life sciences giant is one of at least seven hedge funds that have invested in LianBio, scheduled to go public this week. Here’s why this IPO is different. Stephen Taub October 25, 2021 Joseph Edelman, CEO of Perceptive Advisors. (Chris Goodney/Bloomberg)